Carregant...
PP69. AN AUDIT OF MYELOSUPPRESSION IN PATIENTS WITH GLIOBLASTOMA RECEIVING SIX WEEKS RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY AT THE CHRISTIE
INTRODUCTION: In the “Stupp” EORTC 26981-22981/NCIC CE3 trial, neutropenia (<1.0x10^9/L) or thrombocytopenia (<50x10^9/L) occurred in 4% and 3% respectively of patients during the concurrent phase, and in 4% and 11% respectively of the 78.5% who proceeded to adjuvant temozolomide. This audit w...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5358652/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now293.069 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|